Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.25%
SPX
0.00%
IXIC
+0.31%
FTSE
+0.26%
N225
+1.65%
AXJO
-0.10%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
69.70M
Dividend Yield
0.00%
P/E Ratio
-1.59
EPS
-12.11
Revenue
-
Avg. Volume
40.48K

Recently from Cashu

publisher logo
Cashu

Please provide the text you would like me to summarize.

2 days ago
publisher logo
Cashu

Forte Biosciences R&D Day: Innovations in Autoimmune Treatments and FB102 Unveiling

7 months ago
publisher logo
Cashu

Forte Biosciences Hosts R&D Day to Highlight Innovative Autoimmune Therapy FB102

7 months ago

About

What does FBRX do?
Forte Biosciences, a Dallas-based biopharmaceutical company, specializes in dermatology products and is advancing product candidate FB-102 for autoimmune diseases. The company went public on April 13, 2017, and holds a U.S. patent for skin treatment.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Stocks
Health Care
fbrx
Forte Biosciences
FBRX
-2.72 (-19.23%)
11.445
USD
At close at Jun 25, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials